123 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
Entitlement”).
Page 6 of 29
Return of Materials. The Executive will return to the Company all Company documents, files, manuals, books, software … , copyrightable works of authorship including technical descriptions for products, user guides, illustrations, advertising materials, computer programs
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
14 Nov 23
InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update
4:36pm
presentation materials will be made available on the Company’s website.
Full data and results of the Phase 2 clinical trial will be published shortly
424B3
hdq96idi gmot3o
13 Nov 23
Prospectus supplement
5:05pm
8-K
EX-99.1
gn9 zdwcfipo
2 Nov 23
InMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023
2:56pm
8-K
EX-10.3
583xzxbha
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.1
oyzlh8
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.2
1pk54j4645 jeylbnpjq
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
DEFA14A
pt68y4b
27 Oct 23
Additional proxy soliciting materials
4:08pm
8-K
EX-99.1
0wxaoxq3hhlqj
29 Sep 23
InMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Update
5:18pm
8-K
EX-99.1
e9u35zj0
25 Sep 23
Other Events
4:12pm
8-K
EX-99.1
guuvbdbl dfl0jy
20 Jul 23
Regulation FD Disclosure
2:18pm
424B3
ukweb 7woqbs
15 Dec 22
Prospectus supplement
11:42am